The Market Reports

Synopsis
The global market for D(-) Alpha Parahydroxy Phenylglycine was estimated to be worth US$ 239 million in 2024 and is forecast to a readjusted size of US$ 350 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on D(-) Alpha Parahydroxy Phenylglycine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
D(-) Alpha Parahydroxy Phenylglycine is the D-enantiomer of 4-hydroxyphenylglycine. It is a non-proteinogenic amino acid found in Herpetosiphon aurantiacus.
Main Manufacturers:
The global D(-) Alpha Parahydroxy Phenylglycine market presents an oligopolistic situation. At present, the global key players are mainly distributed in China, among which Apeloa Pharmaceutical is the largest manufacturer of this product, accounting for about 40% of the global market share in 2024.
Market Trend and Drivers:
1. Growing Demand: The demand for D(-) Alpha Parahydroxy Phenylglycine is steadily increasing due to the expanding global antibiotic market, especially the wide usage of semi-synthetic β-lactam antibiotics like amoxicillin.
2. Preference for Green Production: The biosynthesis method of amoxicillin API is gradually becoming the mainstream due to its environmental advantages, which is expected to further boost the demand for D(-) Alpha Parahydroxy Phenylglycine methyl ester used in this process.
3. Increasing Market Concentration: Chinese manufacturers play a significant role in the global market. Leading enterprises in the industry are continuously expanding their scale and improving technology, leading to a gradual increase in market concentration, and the market share of top companies is likely to further expand.
Main Applications:
Amoxicillin production: It is the main application area of ​​​​L-para-hydroxyphenylglycine, which is used to synthesize amoxicillin raw materials and then produce various amoxicillin preparations.
Cephalosporin antibiotic production: It is also important in the synthesis of cephalosporin antibiotics such as cefoperazone, cefoperazone, and cefprozil. With the growth of market demand for these cephalosporin antibiotics, the demand for L-para-hydroxyphenylglycine has also increased accordingly.
This report aims to provide a comprehensive presentation of the global market for D(-) Alpha Parahydroxy Phenylglycine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of D(-) Alpha Parahydroxy Phenylglycine by region & country, by Type, and by Application.
The D(-) Alpha Parahydroxy Phenylglycine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding D(-) Alpha Parahydroxy Phenylglycine.
Market Segmentation
By Company
Apeloa Pharmaceutical
Henan Newland Pharmaceutical
Shanxi Xinbaoyuan Pharmaceutical
Zhejiang Yuntao Biotechnology
Deretil
Daurala Organics
Anhui Jingke Biotechnology
Segment by Type
Content 98.5%
Content 99%
Segment by Application
Amoxicillin
Cephalosporins
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of D(-) Alpha Parahydroxy Phenylglycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of D(-) Alpha Parahydroxy Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of D(-) Alpha Parahydroxy Phenylglycine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index